TNF and neoplasm: Some early preclinical studies were encouraging in this regard; for example blocking TNF with golimumab reduced tumor growth, angiogenesis and metastasis of OSCC in a murine model of orthotopic human OSCC (279), and antagonizing TNF reduced oral cancer proliferation and cytokine production in mice with 4NQO induced oral cancer (135).